Literature DB >> 30972831

Update on protease-activated receptor 2 in cutaneous barrier, differentiation, tumorigenesis and pigmentation, and its role in related dermatologic diseases.

Mason Henehan1, Anna De Benedetto1.   

Abstract

Protease-activated receptor 2 (PAR2) is a transmembrane receptor expressed by multiple tissues, including skin, with rapidly expanding knowledge regarding its roles. In the skin, PAR2 has extensively documented effects in promoting Th2 inflammation and pruritus; and its role in atopic dermatitis continues to be thoroughly studied. Numerous new investigations have shown a more complex range of activities potentially related to dermatologic diseases. Goal of this review is to outline emerging effects of PAR2 activation in the skin other than those related to immunologic and pruritic functions. Specifically, this work seeks to summarize current knowledge (and gaps) of PAR2 as a regulator of epidermal barrier, keratinocyte differentiation, cutaneous tumorigenesis and pigmentation. Additional focus will be placed on possible involvement in dermatologic disease and emergence as a therapeutic target.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  barrier; differentiation; pigmentation; tight junction; tumorigenesis

Year:  2019        PMID: 30972831     DOI: 10.1111/exd.13936

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  5 in total

1.  Protease-activated receptor 2 induces ROS-mediated inflammation through Akt-mediated NF-κB and FoxO6 modulation during skin photoaging.

Authors:  EunJin Bang; Dae Hyun Kim; Hae Young Chung
Journal:  Redox Biol       Date:  2021-05-26       Impact factor: 11.799

Review 2.  Skin Barrier Abnormalities and Immune Dysfunction in Atopic Dermatitis.

Authors:  Gabsik Yang; Jin Kyung Seok; Han Chang Kang; Yong-Yeon Cho; Hye Suk Lee; Joo Young Lee
Journal:  Int J Mol Sci       Date:  2020-04-20       Impact factor: 5.923

Review 3.  Skin barrier defects in atopic dermatitis: From old idea to new opportunity.

Authors:  Takeshi Yoshida; Lisa A Beck; Anna De Benedetto
Journal:  Allergol Int       Date:  2021-12-13       Impact factor: 7.478

Review 4.  Type 2 Inflammation Contributes to Skin Barrier Dysfunction in Atopic Dermatitis.

Authors:  Lisa A Beck; Michael J Cork; Masayuki Amagai; Anna De Benedetto; Kenji Kabashima; Jennifer D Hamilton; Ana B Rossi
Journal:  JID Innov       Date:  2022-04-26

5.  Topical Application of Galgeunhwanggeumhwangryeon-Tang Recovers Skin-Lipid Barrier and Ameliorates Inflammation via Filaggrin-Thymic Stromal Lymphopoietin-Interleukin 4 Pathway.

Authors:  Sang-Hyun Ahn; Su Shin; Yoonju Do; Yunju Jo; Dongryeol Ryu; Ki-Tae Ha; Kibong Kim
Journal:  Medicina (Kaunas)       Date:  2021-12-20       Impact factor: 2.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.